Hsiue, Emily Han-Chung
Howard Hughes Medical Institute · Johns Hopkins University · Johns Hopkins Medicine · Sidney Kimmel Comprehensive Cancer Center
3 papers on CoChatORCID 0000-0001-5882-5142
Most cited papers
- Verified
Targeting a neoantigen derived from a common TP53 mutation
Hsiue, E. H.-C., Wright, K. M., Douglass, J., Hwang, M. S., Mog, B. J., Pearlman, A. H., Paul, S., DiNapoli, S. R., Konig, M. F., Wang, Q., et al. (2021) · Science
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 367
- Verified
Bispecific antibodies targeting mutant RAS neoantigens
Douglass, J., Hsiue, E. H.-C., Mog, B. J., Hwang, M. S., DiNapoli, S. R., Pearlman, A. H., Miller, M. S., Wright, K. M., Azurmendi, P. A., Wang, Q., et al. (2021) · Science Immunology
Monoclonal and Polyclonal Antibodies ResearchCancer Immunotherapy and Biomarkers
Cited by 171
- Verified
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes
Ligon, J. A., Choi, W., Cojocaru, G., Fu, W., Hsiue, E. H.-C., Oke, T. F., Siegel, N., Fong, M. H., Ladle, B., Pratilas, C. A., et al. (2021) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersSarcoma Diagnosis and Treatment
Cited by 124
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free